Wall Street says Valeant likely to win bidding war for Salix
March 12, 2015 at 12:10 PM EDT
Wall Street analysts say Valeant Pharmaceutical’s all-cash bid for Salix Pharmaceuticals is likely to ultimately win out over Endo’s competing offer issued Wednesday.
